-+ 0.00%
-+ 0.00%
-+ 0.00%

VERTEX PHARMACEUTICALS INCORPORATED : UBS RAISES TARGET PRICE TO $640 FROM $615

Reuters·11/03/2026 14:29:49

Please log in to view news